Entero Healthcare Solutions Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors also approved the grant of 49,712 employee stock options under the existing “Entero Employee Stock Option Plan 2023”. The company confirmed its compliance with SEBI (Share Based Employee Benefits) Regulations, 2021.
Financial Performance Reviewed
Entero Healthcare Solutions Limited’s Board of Directors convened on November 4, 2026, to consider and approve the unaudited financial results for the quarter and half-year ending September 30, 2026. These results, both standalone and consolidated, along with the Limited Review Reports from the statutory auditors, were presented and approved.
Employee Stock Option Grant
In addition to financial matters, the Board noted the approval of the Nomination & Remuneration Committee to grant 49,712 (Forty-Nine Thousand Seven Hundred Twelve) Employee Stock Options. These options are part of the company’s existing “Entero Employee Stock Option Plan 2023”, with an exercise price of INR 804 per option. The scheme is stated to be in compliance with the SEBI (Share Based Employee Benefits) Regulations, 2021.
Trading Window Information
Further to a previous intimation, the trading window for dealing in the company’s securities will open 48 hours after the disclosure of the financial results. The details of the grant, including terms and conditions, are provided in Annexure-B.
Financial Highlights (Standalone)
For the quarter ended September 30, 2026, Entero Healthcare reported total income of ₹1,366.53 million and a profit before tax of ₹243.19 million. The total comprehensive income stood at ₹194.21 million. For the half-year ended the same date, total income was ₹2,430.64 million, with a profit before tax of ₹289.24 million and total comprehensive income of ₹226.01 million.
Financial Highlights (Consolidated)
On a consolidated basis for the quarter ended September 30, 2026, total income was reported at ₹20,910.67 million and profit before tax at ₹783.87 million. Total comprehensive income was ₹628.03 million. For the half-year ended September 30, 2026, consolidated total income reached ₹40,345.69 million, with a profit before tax of ₹1,455.07 million and total comprehensive income of ₹1,147.24 million.
Source: BSE
